PRPH Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:00):

Stats
Tagesvolumen	22 056.00
Durchschnittsvolumen	52 045.00
Marktkapitalisierung	83.19M
EPS	$0 ( 2024-03-26 )
Nächstes Ertragsdatum	( $-0.280 ) 2024-05-09
Last Dividend	$0.300 ( 2022-05-24 )
Next Dividend	$0 ( N/A )
P/E	-4.70
ATR14	$0.0230 (0.50%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-17	Karkus Ted William	Buy	400 000	Option (right to buy)
2024-01-01	Latkin Jed	Buy	500 000	Option (right to buy)
2024-01-01	Latkin Jed	Buy	0
2024-03-17	Hirsch Warren	Buy	70 000	Option (right to buy)
2024-03-17	Gleckel Louis Md	Buy	70 000	Option (right to buy)

INSIDER POWER
18.17
Last 98 transactions
Buy: 8 777 863 \| Sell: 8 858 292

Volumen Korrelation

Lang: -0.17 (neutral)

Kurz: 0.34 (neutral)

Signal:(34.867) Neutral

Prophase Labs Inc Korrelation

10 Am meisten positiv korreliert
RMCF	0.955
CLFD	0.955
CRON	0.939
CMRX	0.938
EVLO	0.937
BMRA	0.93
PCSA	0.929
ADP	0.928
DRUG	0.926
BFC	0.922

10 Am meisten negativ korreliert
GXII	-0.94
CFFE	-0.933
ARTEU	-0.933
BRIVU	-0.932
TRHC	-0.932
MSAC	-0.929
VHNA	-0.928
AMTBB	-0.927
EMLD	-0.927
ATEC	-0.926

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Prophase Labs Inc Korrelation - Währung/Rohstoff

-0.70
( moderate negative )

-0.75
( moderate negative )

0.00
( neutral )

-0.66
( moderate negative )

0.44
( neutral )

0.62
( weak )

Prophase Labs Inc Finanzdaten

Annual	2023
Umsatz:	$44.38M
Bruttogewinn:	$16.24M (36.59 %)
EPS:	$-0.980

FY	2023
Umsatz:	$44.38M
Bruttogewinn:	$16.24M (36.59 %)
EPS:	$-0.980

FY	2022
Umsatz:	$122.65M
Bruttogewinn:	$70.65M (57.61 %)
EPS:	$1.170

FY	2021
Umsatz:	$79.04M
Bruttogewinn:	$41.99M (53.12 %)
EPS:	$0.540

Financial Reports:

No articles found.

Prophase Labs Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Prophase Labs Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$1.000	2018-06-06
Last Dividend	$0.300	2022-05-24
Next Dividend	$0	N/A
Payout Date	2022-06-03
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$2.40	--
Avg. Dividend % Per Year	2.00%	--
Score	1.36	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-11-07)

$0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2018	$1.000	44.60%
2019	$0.500	15.40%
2020	$0	0.00%
2021	$0.300	2.84%
2022	$0.600	8.10%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.378	1.500	-7.56	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.183	1.200	-6.09	-7.30	[0 - 0.3]
returnOnEquityTTM	-0.298	1.500	-4.43	-6.64	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.28	0.800	3.59	2.87	[1 - 3]
quickRatioTTM	1.994	0.800	2.98	2.38	[0.8 - 2.5]
cashRatioTTM	0.103	1.500	-0.539	-0.808	[0.2 - 2]
debtRatioTTM	0.142	-1.500	7.63	-10.00	[0 - 0.6]
interestCoverageTTM	-16.95	1.000	-7.39	-7.39	[3 - 30]
operatingCashFlowPerShareTTM	-0.629	2.00	-0.210	-0.419	[0 - 30]
freeCashFlowPerShareTTM	-0.804	2.00	-0.402	-0.804	[0 - 20]
debtEquityRatioTTM	0.264	-1.500	8.94	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.366	1.000	7.24	7.24	[0.2 - 0.8]
operatingProfitMarginTTM	-0.487	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.870	1.000	-5.94	-5.94	[0.2 - 2]
assetTurnoverTTM	0.483	0.800	-0.115	-0.0916	[0.5 - 2]
Total Score				-1.795

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.06	1.000	-0.613	0	[1 - 100]
returnOnEquityTTM	-0.298	2.50	-2.85	-6.64	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.804	2.00	-0.268	-0.804	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.629	2.00	-0.210	-0.419	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0952	1.500	-3.97	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.256	1.000	-8.89	0	[0.1 - 0.5]
Total Score				-2.35

Prophase Labs Inc

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.